Frigate Ventures »

Vyne Therapeutics shares owned by Frigate Ventures

Quarter-by-quarter ownership of Vyne Therapeutics (VYNE) shares owned by Frigate Ventures from 13F filings

Historical chart of Frigate Ventures investment in Vyne Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Vyne Therapeutics held by Frigate Ventures consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vyne Therapeutics by Frigate Ventures

Quarter filed Position value Share count Share price at filing
2025-12-31 $739k 1.3M 0.58

More positions owned by Frigate Ventures

Strategy Option Put Option (MSTR)
Lionsgate Studios Corp Equity (LION)
iShares MSCI Canada ETF Option Put Option (EWC)
AdvisorShares Pure US Cannabis ETF Exchange Traded Fund (MSOS)
Clear Channel Outdoor Holdings Equity (CCO)
Nvidia Corp Equity (NVDA)
Match Group Equity (MTCH)
SPDR S&P 500 ETF Trust Option Put Option (SPY)
New America Acquisition I Corp Equity Unit (NWAX.U)
Five9 Equity (FIVN)
M3-Brigade Acquisition V Corp Equity (MBAV)
FutureCrest Acquisition Corp Equity Unit (FCRS.U)
Blue Water Acquisition Corp III Equity (BLUW)
Texas Ventures Acquisition III Corp Equity (TVA)
Canadian Pacific Kansas City Option Call Option (CP)

View all positions for Frigate Ventures

Top funds holding Vyne Therapeutics

None
Frigate Ventures
Nantahala Capital Management
Baker Bros. Advisors
Acadian Asset Management
KVP Capital Advisors
Vanguard Group
Ikarian Capital
ADAR1 Capital Management
Geode Capital Management
Two Sigma Investments
Susquehanna International
Rangeley Capital
Boothbay Fund Management
XTX Topco

View all funds holding Vyne Therapeutics